FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome...
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
About this item
Full title
Author / Creator
Mostafa, Ahmed , Kandeil, Ahmed , A M M Elshaier, Yaseen , Kutkat, Omnia , Moatasim, Yassmin , Rashad, Adel A , Shehata, Mahmoud , Gomaa, Mokhtar R , Mahrous, Noura , Mahmoud, Sara H , GabAllah, Mohamed , Abbas, Hisham , Taweel, Ahmed El , Kayed, Ahmed E , Kamel, Mina Nabil , Sayes, Mohamed El , Mahmoud, Dina B , El-Shesheny, Rabeh , Kayali, Ghazi and Ali, Mohamed A
Publisher
Switzerland: MDPI
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI
Subjects
More information
Scope and Contents
Contents
(1) Background: Drug repositioning is an unconventional drug discovery approach to explore new therapeutic benefits of existing drugs. Currently, it emerges as a rapid avenue to alleviate the COVID-19 pandemic disease. (2) Methods: Herein, we tested the antiviral activity of anti-microbial and anti-inflammatory Food and Drug Administration (FDA)-ap...
Alternative Titles
Full title
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
Authors, Artists and Contributors
Author / Creator
Kandeil, Ahmed
A M M Elshaier, Yaseen
Kutkat, Omnia
Moatasim, Yassmin
Rashad, Adel A
Shehata, Mahmoud
Gomaa, Mokhtar R
Mahrous, Noura
Mahmoud, Sara H
GabAllah, Mohamed
Abbas, Hisham
Taweel, Ahmed El
Kayed, Ahmed E
Kamel, Mina Nabil
Sayes, Mohamed El
Mahmoud, Dina B
El-Shesheny, Rabeh
Kayali, Ghazi
Ali, Mohamed A
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e5c8f820f005463d9184f68f09ab381d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e5c8f820f005463d9184f68f09ab381d
Other Identifiers
ISSN
1424-8247
E-ISSN
1424-8247
DOI
10.3390/ph13120443
